Archives for June 9, 2016

Dispatches from BIO

GE and PnuVax ink vaccine deal and say single-use will change the industry

Single-use technology is driving a new era in vaccine development says PnuVax which has acquired IP from GE Healthcare to produce an inactivated yellow fever vaccine.

Lonza to make commercial gene therapies for Bluebird bio at new Texas site

Increased demand for gene therapy services will drive further investment in Lonza's capabilities, the firm says as it inks a strategic deal with Bluebird.

Cristália gets ANVISA nod to make burns treatment at new biomanufacturing plant

Brazil’s ANVISA has cleared Cristália Laboratory to make an API for an over-the-counter (OTC) burns treatment at a recently established $40m biomanufacturing facility in Itapira, Sao Paulo.

Replicating DNA structures is key to faster gene therapy vector manufacturing says Touchlight

Replicating secondary structures in viral DNA could be key to developing to faster AAV vector production methods according to UK tech firm Touchlight.